Short Sellers Cannot Make Up Their Minds About Social Media
The January 29 short interest data have been compared with the previous report, and short interest was mixed in these selected social media stocks for this settlement date.
All Work
Chris Lange
Mixed Views on Short Interest in Cybersecurity
The January 29 short interest data have been compared with the previous figures, and short interest for the selected cybersecurity stocks was mixed.
Disney Earnings Appear to Not Be Enough for Investors
The Walt Disney Company (NYSE: DIS) reported fiscal first quarter financial results after the markets closed on Tuesday. The company had $1.63 in earnings per share (EPS) on $15.24 billion in revenue compared to…
SEC Charges Connecticut Executive With Insider Trading
The SEC alleged that Dennis Wayne Hamilton made more than $130,000 in illegal profits by trading on nonpublic information he learned on the job.
What to Look for in Cisco Earnings
Cisco Systems is scheduled to report its fiscal second-quarter earnings after the markets close on Wednesday.
Adaptimmune Receives Breakthrough Designation From FDA
Adaptimmune Therapeutics has announced that the FDA granted a Breakthrough Therapy designation for the company's affinity enhanced T-cell therapy.
Cerus Announces New Partnership With Red Cross
Cerus led the bulls in Tuesday’s trading session on news of a new partnership with one of the biggest charities in the world.
Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)
Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating with a $39 price target.
SEC Charges Manhattan Firm With Fraud
The SEC has announced fraud charges against American Growth Funding, a Manhattan-based lending company, and its owner is accused of repeatedly lying to investors purchasing high-yield securities.
What to Expect From Disney Earnings
Walt Disney is expected to report its fiscal first-quarter financial results after the markets close on Tuesday.
Regeneron Falls on Missed Earnings
Regeneron Pharmaceuticals reported disappointing fourth-quarter financial results before the markets opened on Tuesday.
How Analysts View GoPro After Q4 Earnings
After GoPro reported its fourth-quarter financial results after the markets closed on Wednesday, analysts began cutting their price targets.
Why Analysts Are Slashing Tableau Software Expectations
Tableau Software Inc. (NYSE: DATA) saw its earnings report turn into an unexpected loss, and the company posted lower than expected license revenues. The news was bad enough that it looks like the entire…
How Analysts View Pfizer and Merck After Earnings
After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical giants.
Analysts Cooling on Match After Q4 Earnings
Match reported its fourth-quarter financial results on Tuesday, but after the report, analysts began to reconsider how they viewed the company.
How Analysts Value Gilead Now After Earnings
After Gilead Sciences reported fourth-quarter financial results on Tuesday, analysts weighed in on this biotech giant and in what direction it might go next.
Analysts Get Even More Bullish in Take-Two
24/7 Wall St. has reviewed a few analyst calls that came after the company Take-Two Interactive Software posted its results and most were fairly positive.
4 Companies That Destroyed Shareholders Last Week
24/7 Wall St. examines LinkedIn, Gopro and some other companies that punished shareholders over the course of the past week.
How Analysts View Chipotle After a Kitchen-Sink Earnings Report
Chipotle Mexican Grill fourth-quarter financial results were the first report after the E. coli scare. As a result, analysts poured into the stock, speculating on where it might go next.
Top 4 BioPharma Movers of the Week
Over the past week, Alere and a few biotech other companies made absolutely massive runs, either up and down.